Article ID Journal Published Year Pages File Type
5433763 Journal of Controlled Release 2017 10 Pages PDF
Abstract

Amphotericin B (AmB) has been widely used against fungal infections throughout almost the entire body, including the skin, nails, oral cavity, respiratory tract, and urinary tract. However, the development of AmB-loaded nanoparticles demands a novel technique that reduces its toxicity and other associated problems. Here, we developed a pH-responsive and redox-sensitive polymer-based AmB-delivery carrier system. In particular, this system was functionalized by conjugation with the antifungal peptide histatin 5, which acts both as a targeting ligand and a synergistic antifungal molecule against Candida albicans, a major systemic fungal pathogen of humans. Our results in vitro and in vivo suggest that this drug-delivery system may serve as a novel tool to facilitate the use of antimicrobial peptides as targeting ligands to pathogenic microbes, which would open new avenues of investigation in the field of drug delivery.

Graphical abstractSchematic illustration of a nanoparticle conjugated with histatin 5 and Amphotericin B, as well as GSH- or Trx-mediated drug release.Download high-res image (180KB)Download full-size image

Related Topics
Physical Sciences and Engineering Materials Science Biomaterials
Authors
, , , , , , , , ,